That's a gross oversimplification of a very common business practice used in both corporate applications and especially in health.Proper guidance is invaluable. Especially when dealing with FDA like entities.
That's a gross oversimplification of a very common business...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.0¢ |
Change
-0.005(3.23%) |
Mkt cap ! $80.64M | |||
| Open | High | Low | Value | Volume |
| 15.0¢ | 15.0¢ | 15.0¢ | $534 | 3.559K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 105000 | 14.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.0¢ | 39096 | 1 |
View Market Depth
| Last trade - 14.51pm 09/08/2024 (20 minute delay) ? |
| EIQ (ASX) Chart |